News & Comment

Filter By:

  • We celebrate the fifteenth anniversary of Nature Nanotechnology by looking at how the journal topics have expanded throughout the years.

    Editorial
  • Almost all currently used vaccines against COVID-19 consist of either non-viral or viral nanoparticles. Here we attempt to understand the reasons behind the success of such advanced nanoscale vaccine technologies compared with clinically established conventional vaccines, and the lessons to be learnt from this potentially transformative development in the adoption and acceptance of nanotechnology for medicine.

    • Thomas Kisby
    • Açelya Yilmazer
    • Kostas Kostarelos
    Comment
  • Sharing the step-by-step procedures necessary to fabricate nanostructures could optimize efforts to achieve reproducible devices.

    • Mohammad J. Bereyhi
    • Tobias J. Kippenberg
    Comment
  • The FAIR principles provide compelling guidelines on how to achieve reusability of nanotechnology data.

    Editorial
  • The challenge of assessing the scope and magnitude of risk from nanomaterials is urgent for society and ignoring risks could be detrimental for development. This challenge is bigger than the individual capacities on each side of the Atlantic, but effective cross-Atlantic collaboration can solve essential riddles about the use of nanomaterials.

    • Janeck James Scott-Fordsmand
    • Mónica João de Barros Amorim
    • Christine Ogilvie Hendren
    Comment
  • Research on nanoplastic has already provided some significant results but it has also exposed a large number of open questions.

    Editorial
  • The nanotechnology-enabled mRNA-based vaccine platform recently approved against COVID-19 bears hope for improved vaccine development and trialling capacities in low- and middle-income countries as part of a broader global public health agenda.

    • Steffi Friedrichs
    • Diana M. Bowman
    Comment
  • To achieve the biggest impact, nanotechnology-based strategies developed to manage infectious diseases in resourced-limited settings need to take into account the local context.

    Editorial
  • Sharing protocols with the end-users may allow their flexible implementation to produce nanotechnology solutions for global health challenges that better cater for local needs.

    • Jose Gomez-Marquez
    • Kimberly Hamad-Schifferli
    Comment
  • When developing nanotechnology solutions for global health it is important to be mindful of the ethical, environmental, socio-economical, cultural and legal aspects associated with their deployment.

    • Fabio Salamanca-Buentello
    • Abdallah S. Daar
    Comment
  • We have launched a series of webinars to engage our audience in a way that is complementary to the publication of articles.

    Editorial
  • Flexibly designed nanomaterials can trigger specific immune responses and might offer promising alternatives to traditional immunosuppressive therapies, cancer immunotherapies and vaccine formulations.

    Editorial
  • Two nanoparticle-based vaccines close to obtaining approval by the US Food and Drug Administration could represent a giant step in the fight against the COVID-19 pandemic.

    Editorial
  • After fourteen years of writing for Nature Nanotechnology, Chris Toumey reflects on the role of experts in Science and Technology Studies in his last contribution to the journal.

    • Chris Toumey
    Thesis
  • Although the idea of using nanomaterials for agriculture is promising, we must consider in detail how nanotechnology can provide advantages over standard tools.

    Editorial